4211 No. 3 Road Richmond BC Canada V6X 2C3
(604) 285 9975
Mon – Fri: 9:00 – 17:00
Our Products introduction
We seek investment opportunities in start-ups and innovators in the: pharmaceutical; medical devices, sciences, and services, and nutrition industries.
Breakthrough medical equipment, pharmaceutical and nutraceutical technologies from North America
Innovative medical processes and practices
New solutions in public and private health management
North America is the world’s largest health market with numerous exceptional research institutions. Most of the companies in North American medical sector are small and medium-sized enterprises engaged in the research and development of innovative technologies, products and solutions. To succeed, these companies need investment and assistance to advance beyond the product development stage. Lipont Caus Capital can help North American companies succeed in North America and China. Located in Richmond, British Columbia, we provide one-stop service for pioneering entrepreneurs and enterprises. Through our Libang Group colleagues we can assist North American companies to develop, commercialize and sell their products into China.
Improved health care is a priority in China. The government continues to increase investment to ensure that the entire population enjoys basic medical and health services and encouraged social investment to improve service quality. The embrace of modern medical capabilities and institutional reform has created opportunities for private investment in the health industry and profoundly affected the market structure.
The health care market is huge, but under-developed. And, it is growing rapidly, driven by an aging population, urbanization, increasing personal wealth, changing expectations and growing government and private sector investment. It is projected by Statistica that in 2018 China will spend USD 800 billion on public health. Moreover, as reported by the Organization for Economic Cooperation and Development, at 5.6% of GNP, China’s annual health care expenditure is prudent and sustainable, and has capacity to grow further in the future.
We want to work with medical and health entrepreneurs with interests advanced medical technology, medical device manufacturing, and health policy and program reform. We provide equity investment, incubation and guidance, to create future leaders in the industry.
Scientific research strength
Five R&D bases
Four production bases
Anaesthesia Meds, Medical Nutrition, AI in medical use, Instruments + Systems used in Day Surgery
We actively seek Innovations and startups (I/O Teams) in the field of health (medicine, medical devices, health solutions, health products, medical services, etc.)